Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METFORMIN\SITAGLIPTIN for Hypertension: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 10 adverse event reports in the FDA FAERS database where METFORMIN\SITAGLIPTIN was used for Hypertension.

Most Reported Side Effects for METFORMIN\SITAGLIPTIN

Side Effect Reports % Deaths Hosp.
Blood glucose increased 709 8.1% 17 150
Acute kidney injury 616 7.0% 93 422
Lactic acidosis 557 6.3% 132 313
No adverse event 539 6.1% 0 1
Diarrhoea 513 5.8% 24 152
Inappropriate schedule of drug administration 469 5.3% 113 186
Product dose omission issue 452 5.1% 0 21
Pancreatic carcinoma 431 4.9% 280 125
Drug ineffective 384 4.4% 31 57
Nausea 378 4.3% 40 118
Diabetes mellitus inadequate control 364 4.1% 40 70
Vomiting 343 3.9% 32 168
Pancreatitis 307 3.5% 57 203
Weight decreased 284 3.2% 17 101
Death 248 2.8% 247 86

Other Indications for METFORMIN\SITAGLIPTIN

Diabetes mellitus (2,606) Type 2 diabetes mellitus (2,471) Product used for unknown indication (825) Blood glucose increased (51) Blood glucose abnormal (47) Diabetes mellitus management (41) Insulin-requiring type 2 diabetes mellitus (29) Blood glucose (28) Type 1 diabetes mellitus (28) Glycosylated haemoglobin increased (20)

Other Drugs Used for Hypertension

AMLODIPINE (20,207) LISINOPRIL (11,824) RAMIPRIL (10,210) VALSARTAN (8,956) LOSARTAN (7,966) FUROSEMIDE (7,490) HYDROCHLOROTHIAZIDE (7,119) METOPROLOL (5,918) OLMESARTAN MEDOXOMIL (5,702) BISOPROLOL (5,520)

Related Pages

METFORMIN\SITAGLIPTIN Full Profile All Hypertension Drugs METFORMIN\SITAGLIPTIN Demographics METFORMIN\SITAGLIPTIN Timeline